About PharmEasy Unlisted Shares
Pharmeasy Share Price Full Details About the Company PharmEasy is India’s leading digital healthcare platform. It covers information, discussion, individual tests, drugs, healthcare products, and services from registered and trusted apothecaries, leading individual laboratories, and trusted croakers
across the length and breadth of India reaching majorly all livable postal canons of the country and serving to a elevation line, which was firstly started in the time 2015 by its authors Dharmil Sheth, an MBA from IMT Ghaziabad and Dr. Dhaval Shah, MBBS from Rajiv Gandhi Medical College and MBA from XLRI Jamshedpur.
Overview of PharmEasy
According to the RedSeer Report, they’re India’s largest digital healthcare platform( grounded upon GMV of products and services vended for the time ended March 31, 2021). They operate an integrated, end- to- end business that aims to give results for the healthcare requirements of consumers across the following critical stages A. furnishing digital tools and information about illness and heartiness. B. Offering Teleconsultation. C. Providing diagnostics and Radiology tests. D. delivering treatment protocols including products and bias. PharmEasy custom- erected personal technology, unified data platforms, force chain capabilities, and a deep understanding of the dynamic interplay that happens among the colorfulsub-segments of India’s healthcare request are what set us piecemeal. These capabilities enable PharmEasy to offer localized service to its entire value chain, viz.( a) channel noncommercial, retail, druggist/ institution;( b) adviser hospitals;( c) consumers; and( d) companies pharmaceutical, nutraceutical, and medical bias.
The businesses are spreadpan-India, with last- afar delivery capabilities into over 18,587 leg canons( for June 2021) through the PharmEasy business, making it affordable for the average man.
Fundamentals
Per Equity Share
Financial
P&L Statement
| P&L Statement | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 2335 | 5729 | 6644 | 5664 |
| Cost of Material Consumed | 2267 | 5342 | 5669 | 4737 |
| Gross Margins | 2.91 | 6.76 | 14.67 | 16.37 |
| Change in Inventory | -114 | -229 | 62 | 143 |
| Employee Benefit Expenses | 270 | 1459 | 1283 | 699 |
| Other Expenses | 482 | 1502 | 1051 | 731 |
| EBITDA | -570 | -2345 | -1421 | -646 |
| OPM | -24.41 | -40.93 | -21.39 | -11.41 |
| Other Income | 25 | -1185 | -2866 | 931 |
| Finance Cost | 43 | 258 | 666 | 728 |
| D&A | 33 | 159 | 243 | 216 |
| EBIT | -603 | -2504 | -1664 | -862 |
| EBIT Margins | -25.82 | -43.71 | -25.05 | -15.22 |
| PBT | -621 | -3977 | -5196 | -2522 |
| PBT Margins | -26.6 | -69.42 | -78.21 | -44.53 |
| Tax | 21 | 22 | 15 | 11 |
| PAT | -642 | -3999 | -5211 | -2533 |
| NPM | -27.49 | -69.8 | -78.43 | -44.72 |
| EPS | -25.08 | -6.51 | -8.48 | -3.9 |
Financial Ratios |
2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Operating Profit Margin | -24.41 | -40.93 | -21.39 | -11.41 |
| Net Profit Margin | -27.49 | -69.8 | -78.43 | -44.72 |
| Earning Per Share (Diluted) | -25.08 | -6.51 | -8.48 | -3.9 |
Balance Sheet
| Assets | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Fixed Assets | 128 | 1025 | 912 | 734 |
| CWIP | 0.2 | 7.8 | 4 | 3.6 |
| Investments | 1 | 438 | 342 | 329 |
| Trade Receivables | 358 | 861 | 905 | 706 |
| Inventory | 406 | 761 | 688 | 556 |
| Other Assets | 4011.8 | 8305.2 | 5405 | 6061.4 |
| Total Assets | 4905 | 11398 | 8256 | 8390 |
| Liabilities | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Share Capital | 25.6 | 614.2 | 614.2 | 649.6 |
| FV | 1 | 1 | 1 | 1 |
| Reserves | 3555.4 | 6408.3 | 1823 | 1938 |
| Borrowings | 585 | 2585 | 4120 | 4098 |
| Trade Payables | 365 | 459 | 413 | 413 |
| Other Liabilities | 374 | 1331.5 | 1285.8 | 1291.4 |
| Total Liabilities | 4905 | 11398 | 8256 | 8390 |
Cash-Flow Statement
| Cash-Flow Statement | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| PBT | -620 | -3971 | -5196 | -2522 |
| OPBWC | -427 | -1474 | -637 | -214 |
| Change in Receivables | -99 | -226 | -112 | 30 |
| Change in Inventories | -112 | -195 | 73 | 133 |
| Change in Payables | 74 | -18 | -45 | -0.5 |
| Other Changes | -238 | -592 | 39 | 26.5 |
| Working Capital Change | -375 | -1031 | -45 | 189 |
| Cash Generated From Operations | -802 | -2505 | -682 | -25 |
| Tax | -12 | -84 | -62 | -36 |
| Cash Flow From Operations | -814 | -2589 | -744 | -61 |
| Purchase of PPE | -31 | -143 | -95 | -72 |
| Sale of PPE | 1 | 5 | 8 | 10 |
| Cash Flow From Investment | 4 | -5789 | -72 | -1261 |
| Borrowing | 15 | 2016 | 652 | -231 |
| Divided | 0 | 0 | -23 | -29.5 |
| Equity | 399.2 | 6344 | 548 | 2000 |
| Others From Financing | 605.8 | -55 | -324 | -282.5 |
| Cash Flow from Financing | 1020 | 8305 | 853 | 1457 |
| Net Cash Generated | 210 | -73 | 37 | 135 |
| Cash at the Start | 20 | 230 | 157 | 192 |
| Cash at the End | 230 | 157 | 194 | 327 |
